|
Q4 2019
Filed on Feb 14, 2020
|
53,432
|
$6.97 - $8.48
$372K - $453K
|
|
|
Q4 2019
Filed on Feb 14, 2020
|
419,155
|
N/A
|
|
|
Q4 2019
Filed on Feb 14, 2020
|
62,998
|
N/A
|
|
|
Q4 2019
Filed on Feb 14, 2020
|
112,339
|
$4.51 - $8.16
$507K - $917K
|
|
|
Q4 2019
Filed on Feb 14, 2020
|
164,990
|
N/A
|
|
|
Q4 2019
Filed on Feb 14, 2020
|
395,036
|
N/A
|
|
Foamix Pharmaceuticals Ord
|
Q4 2019
Filed on Feb 14, 2020
|
23,627
|
N/A
|
|
|
Q4 2019
Filed on Feb 14, 2020
|
1,594
|
$48.28 - $54.19
$77K - $86.4K
|
|
|
Q4 2019
Filed on Feb 14, 2020
|
263,670
|
N/A
|
|
Twlo 0.250 06/01/23 Cvt Convertible 0.250 01 Jun 23
|
Q4 2019
Filed on Feb 14, 2020
|
1,000,000
|
N/A
|
|
Avantor Mandty Con Srs A Prf Convertible Preferred 0.000
|
Q4 2019
Filed on Feb 14, 2020
|
30,000
|
N/A
|
|
|
Q4 2019
Filed on Feb 14, 2020
|
145,288
|
$6.07 - $8.74
$882K - $1.27M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
71,372
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
28,600
|
$39.42 - $50.84
$1.13M - $1.45M
|
|
Svra Jul9 12.5 C 19 Jul 19 12.50 Call
|
Q3 2019
Filed on Nov 12, 2019
|
8,100
|
N/A
|
|
Chk Jul9 4.0 C 19 Jul 19 4.00 Call
|
Q3 2019
Filed on Nov 12, 2019
|
20,000
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
2,257
|
N/A
|
|
Srdx Aug9 45.0 C 16 Aug 19 45.00 Call
|
Q3 2019
Filed on Nov 12, 2019
|
23,300
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
55,964
|
$4.53 - $5.44
$254K - $304K
|
|
Mdco 2.750 07/15/23 Cvt Convertible 2.750 15 Jul 23
|
Q3 2019
Filed on Nov 12, 2019
|
5,650,000
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
34
|
$38.66 - $47.41
$1.31K - $1.61K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
39,241
|
N/A
|
|
Zgnx Jul9 35.0 P 19 Jul 19 35.00 Put
|
Q3 2019
Filed on Nov 12, 2019
|
14,500
|
N/A
|
|
Tdg Jul9 440.0 P 19 Jul 19 440.00 Put
|
Q3 2019
Filed on Nov 12, 2019
|
7,485
|
N/A
|
|
Xlnx Jan0 140.0 C 17 Jan 20 140.00 Call
|
Q3 2019
Filed on Nov 12, 2019
|
30,000
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
377,080
|
$0.26 - $0.56
$98K - $211K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
151,074
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
162,800
|
$1.54 - $2.06
$251K - $335K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
1,322
|
$62.5 - $64.93
$82.6K - $85.8K
|
|
Cnat Jul9 5.0 C 19 Jul 19 5.00 Call
|
Q3 2019
Filed on Nov 12, 2019
|
600
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
2,167
|
$38.59 - $39.55
$83.6K - $85.7K
|
|
Itci Aug9 20.0 C 16 Aug 19 20.00 Call
|
Q3 2019
Filed on Nov 12, 2019
|
51,200
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
321
|
$59.2 - $63.13
$19K - $20.3K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
1,435
|
$56.94 - $59.14
$81.7K - $84.9K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
1,131,341
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
88,446
|
N/A
|
|
Hznp 2.500 03/15/22 Cvt Convertible 2.500 15 Mar 22
|
Q3 2019
Filed on Nov 12, 2019
|
1,103,000
|
N/A
|
|
Sanofi Contingent Value Rts Rights
|
Q3 2019
Filed on Nov 12, 2019
|
28,979
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
112,384
|
$5.65 - $7.3
$635K - $820K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
264,117
|
$0.61 - $2.21
$161K - $584K
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
15,800
|
$219.29 - $241.72
$3.46M - $3.82M
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
114,886
|
$2.16 - $2.95
$248K - $339K
|
|
Intercept Pharmaceuticals In
|
Q2 2019
Filed on Aug 14, 2019
|
4,944,000
|
N/A
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
73,000
|
$5.42 - $9.65
$396K - $704K
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
158,343
|
$0.54 - $1.33
$85.5K - $211K
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
5,000,000
|
N/A
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
9,706,000
|
N/A
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
15,119
|
N/A
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
1,500,000
|
N/A
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
17,000
|
N/A
|
|